immunitor.com
About company
Since 2000, Immunitor has been developing orally-delivered immunotherapies for a number of serious diseases affecting the world. Immunitor products are used as means of preventing and/or treating viral infections such as HIV, hepatitis B and C, influenza, tuberculosis, broad-spectrum bacterial and fungal infections, cancer; and atherosclerosis/obesity. Immunitor Inc. is the global holding corporation for Immunitor product and manufacturing rights and assets. Currently, Immunitor has GMP manufacturing capability in Thailand. Specific Immunitor products are registered in several Asian and African countries. Immunitor CEO is Dr. Aldar S. Bourinbaiar, the manufacturing plant is run by Mr. Vichai Jirathitikal. These two individuals are the respective main shareholders of the company.
